Yahoo
OTC Markets OTCQX - Delayed Quote USD

Jushi Holdings Inc. (JUSH)

0.4700 +0.0200 (+4.44%)
As of 9:41:22 AM EST. Market Open.
Chart Range Bar
Loading chart for JUSH
  • Previous Close 0.4500
  • Open 0.4700
  • Bid 0.4457 x 2000000
  • Ask 0.4675 x 2200000
  • Day's Range 0.4700 - 0.4700
  • 52 Week Range 0.3400 - 0.9070
  • Volume 8,000
  • Avg. Volume 189,323
  • Market Cap (intraday) 93.863M
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2800
  • Earnings Date Oct 28, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 1.50

Jushi Holdings Inc. engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States. The company offers flower, vapes, concentrates, infused chews and chocolates, tinctures, capsules, softgels, topicals and RSO, pre-rolls, and infused chocolate bites under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, Sèche, Shayo, and Carm's Delight Bites brands. It also engages in the sale of bulk raw materials to duly licensed third parties for use in its own finished products. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature's Remedy, and NuLeaf brands. It serves small local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.

jushico.com

1,288

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

JUSH
24.44%
S&P/TSX Composite index (^GSPTSE)
12.35%

1-Year Return

JUSH
21.67%
S&P/TSX Composite index (^GSPTSE)
18.93%

3-Year Return

JUSH
2.49%
S&P/TSX Composite index (^GSPTSE)
80.59%

5-Year Return

JUSH
87.02%
S&P/TSX Composite index (^GSPTSE)
66.86%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 70.47M
Earnings -12.52M
Profit Margin -17.76%

Q3

FY25

Q4

FY25

Q2

FY26

Q3

FY26

-20M
0
20M
40M
60M
-35.0%
-30.0%
-25.0%
-20.0%
-15.0%

Analyst Insights

View More

Analyst Price Targets

1.50
1.50 Average
0.4700 Current
1.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.98%

  • Return on Assets (ttm)

    1.61%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    276.54M

  • Net Income Avi to Common (ttm)

    -55.25M

  • Diluted EPS (ttm)

    -0.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.73M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    604k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: